BioNexus Gene Lab Ownership | Who Owns BioNexus Gene Lab?

BioNexus Gene Lab Ownership Summary

BioNexus Gene Lab is owned by 0.01% institutional investors, 35.59% insiders, and 64.40% retail investors.

BGLC Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	BioNexus Gene Lab	0.01%	35.59%	64.40%
Sector	Healthcare Stocks	35.38%	11.35%	53.27%
Industry	Diagnostics & Research Stocks	50.85%	10.56%	38.59%

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	2	100.00%	232	-99.51%	-	0.14%	2	100.00%	-	-
Dec 31, 2025	1	-50.00%	47,830	114.71%	2	167.55%	1	-	-	-100.00%
Sep 30, 2025	2	100.00%	22,277	132.97%	1	437.75%	1	-	1	-
Jun 30, 2025	1	-	9,562	-	-	-	1	-	-	-

BGLC Ownership FAQ

Who Owns BioNexus Gene Lab?

BioNexus Gene Lab shareholders are primarily institutional investors at 0.01%, followed by 35.59% insiders and 64.40% retail investors. The average institutional ownership in BioNexus Gene Lab's industry, Diagnostics & Research Stocks, is 50.85%, which BioNexus Gene Lab falls below.

Does Blackrock own BioNexus Gene Lab?

BlackRock is not among the top 10 institutional shareholders of BioNexus Gene Lab.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools